Objective:

To explore metabolite-induced metabolic reprogramming in the immune system.

Approach:

• Historical Context: The concept of metabolic reprogramming dates back to the 1920s with Otto Warburg's discovery of aerobic glycolysis in tumor cells.
• Research Focus: The editorial discusses five papers addressing various aspects of metabolic reprogramming in immune cells, including macrophages and neutrophils.

Key Findings:

• TMAO, a gut-derived metabolite, is linked to inflammatory bowel disease (IBD).
• Macrophage metabolic profiles vary by location and are influenced by diet and microbiota.
• Platelets influence neutrophil metabolic reprogramming.
• Transcriptional regulators NLRC5 and CIITA are important for MHC class I and II gene expression.
• Free heme is involved in sepsis and various forms of cell death.

Interpretation:

The findings suggest a complex interplay between metabolites and immune cell function, highlighting potential therapeutic avenues.

Limitations:

• The editorial does not provide experimental data to support the hypotheses.
• Further research is needed to confirm the mechanisms of metabolic reprogramming.

Conclusion:

Metabolite-induced metabolic reprogramming in the immune system presents a rich area for future research.